Here are the first four investments from Venture Investors’ new $75M health VC fund
168723
post-template-default,single,single-post,postid-168723,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Here are the first four investments from Venture Investors’ new $75M health VC fund

Venture Investors

Here are the first four investments from Venture Investors’ new $75M health VC fund

Invenra Inc., a Madison startup that developed a drug discovery platform to identify human multi-specific antibodies for immuno-oncology, is one of the four startups to receive an investment from Wisconsin’s Venture Investors.

The funding comes from the venture capital investment group’s new $75 million fund dedicated to health startups, which will be managed from Madison, Ann Arbor, Michigan, and Milwaukee.

READ FULL STORY